A next-generation Stockholm3 blood test detected aggressive prostate cancer more accurately than PSA, improving early ...
MedPage Today on MSN
Multicomponent test tops PSA for clinically significant prostate cancers
Blood-based biomarker test had similar false-positive rate as PSA, while reducing false ne ...
A next-generation blood test could improve early detection of the most dangerous forms of prostate cancer. "The major ...
The major challenge in prostate cancer screening is not just to find more cancer cases, but to identify the cancers that are ...
A new blood test may make it easier to detect the most dangerous forms of prostate cancer early. In a study from Karolinska ...
New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress ...
A pioneering blood test detected more than twice as many high-risk prostate cancer cases as current methods, paving the way for more effective screening.
IT’S the most common cancer in the UK, but caught early, the chances of surviving prostate cancer are very high. While in ...
Only about 6% of men have had a documented discussion with their primary care doctor about prostate cancer screening, even ...
When high-profile figures publicly discuss their prostate cancer, the public health impact can be immediate. The media ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results